Zobrazeno 1 - 10
of 72
pro vyhledávání: '"ALZHEIMER DISEASE/DRUG THERAPY"'
Autor:
Maria Teresa Cruz, Catarina Oliveira
Publikováno v:
Revista Portuguesa de Farmacoterapia, Vol 13, Iss 3 (2022)
Alzheimer’s disease (AD) is a chronic, progressive and fatal neurodegenerative disease, and is considered to be the main cause of dementia. It is currently one of the most prevalent diseases in the world, counting with millions of people suffering
Externí odkaz:
https://doaj.org/article/2218d57d0b6241cbba114ac2d50be8e8
Autor:
Kjerstin Tevik, Jūratė Šaltytė Benth, Marte Aarøen, Marie Turmo Lornstad, Sverre Bergh, Anne‐S. Helvik
Publikováno v:
Health Science Reports, Vol 4, Iss 3, Pp n/a-n/a (2021)
Abstract Aims To describe the prevalence and persistence of analgesic drug use (opioids and antipyretics [ie, paracetamol and acetylsalicylic acid]) in participants (≥70 years) with and without dementia receiving domiciliary care in the eastern par
Externí odkaz:
https://doaj.org/article/6c6042fce24b43d3b287f7000204849b
Publikováno v:
Journal of Neural Transmission. 129:773-804
The novel antibiotic-exploiting strategy in the treatment of Alzheimer's (AD) and Parkinson's (PD) disease has emerged as a potential breakthrough in the field. The research in animal AD/PD models provided evidence on the antiamyloidogenic, anti- inf
Autor:
Chitima Boongird, Worapong Tearneukit, Wannisa Wongpipathpong, Gareth J McKay, Ammarin Thakkinstian
Publikováno v:
Boongird, C, Tearneukit, W, Wongpipathpong, W, McKay, G J & Thakkinstian, A 2022, ' Efficacy of pharmacotherapy and non-pharmacotherapy of Alzheimer dementia: A protocol for systematic review and meta-analysis ', Medicine, vol. 101, no. 50, e32382 . https://doi.org/10.1097/MD.0000000000032382
BACKGROUND: Alzheimer disease (AD) is the most common cause of dementia worldwide. Despite the publication of numerous systematic reviews and meta-analyses that have summarized the evidence associated with pharmacotherapies (PTs) and non-pharmacother
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9445bb257b676277540c7ab512973e18
https://pure.qub.ac.uk/en/publications/fb876d68-9348-4b70-a927-8d99d98561ec
https://pure.qub.ac.uk/en/publications/fb876d68-9348-4b70-a927-8d99d98561ec
Autor:
Natalia Ortí-Casañ, Inge S. Zuhorn, Petrus J. W. Naudé, Peter P. De Deyn, Pauline E. M. van Schaik, Harald Wajant, Ulrich L. M. Eisel
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 119(37). NATL ACAD SCIENCES
Tumor necrosis factor-α (TNF-α) is a pleiotropic, proinflammatory cytokine related to different neurodegenerative diseases, including Alzheimer’s disease (AD). Although the linkage between increased TNF-α levels and AD is widely recognized, TNF-
Autor:
Karin Taş, Beatrice Dalla Volta, Christina Lindner, Omar El Bounkari, Kathleen Hille, Yuan Tian, Xènia Puig-Bosch, Markus Ballmann, Simon Hornung, Martin Ortner, Sophia Prem, Laura Meier, Gerhard Rammes, Martin Haslbeck, Christian Weber, Remco T. A. Megens, Jürgen Bernhagen, Aphrodite Kapurniotu
Publikováno v:
Nature Communications, 13(1):5004. Nature Publishing Group
Amyloid self-assembly is linked to numerous devastating cell-degenerative diseases. However, designing inhibitors of this pathogenic process remains a major challenge. Cross-interactions between amyloid-β peptide (Aβ) and islet amyloid polypeptide
Autor:
Gabriel Servilha-Menezes, Rui M.P. da Silva-Júnior, Melita Salkovic-Petrisic, Suélen Santos Alves, Jan Homolak, Norberto Garcia-Cairasco
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
Almost 115 years ago, Alois Alzheimer described Alzheimer’s disease (AD) for the first time. Since then, many hypotheses have been proposed. However, AD remains a severe health public problem. The current medical approaches for AD are limited to sy
Publikováno v:
Repositorio UN
Universidad Nacional de Colombia
instacron:Universidad Nacional de Colombia
Universidad Nacional de Colombia
instacron:Universidad Nacional de Colombia
ilustraciones, fotografías, gráficas, tablas La Enfermedad de Alzheimer (EA) es la demencia más común, un desorden neurodegenerativo de carácter multifactorial caracterizado por la presencia de placas amiloides, ovillos neurofibrilares, reducci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::f4a8f313415f2a19a9ba965f1e50adb7
https://repositorio.unal.edu.co/handle/unal/81720
https://repositorio.unal.edu.co/handle/unal/81720
Autor:
Andrzejewski, Kryspin, Jampolska, Monika, Mojzych, Ilona, Conde, Silvia V, Kaczyńska, Katarzyna
Despite the severe respiratory problems reducing the quality of life for Alzheimer's disease (AD) patients, their causes are poorly understood. We aimed to investigate hypoxic and hypercapnic respiratory responses in a transgenic mouse model of AD (A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1437::eb0ca6702d97316bf40fafafd1b810e6
https://hdl.handle.net/10362/141513
https://hdl.handle.net/10362/141513
Autor:
Areti Angeliki Veroniki, Huda M Ashoor, Patricia Rios, Georgios Seitidis, Lesley Stewart, Mike Clarke, Catrin Tudur-Smith, Dimitris Mavridis, Brenda R Hemmelgarn, Jayna Holroyd-Leduc, Sharon E Straus, Andrea C Tricco
Publikováno v:
Veroniki, A A, Ashoor, H M, Rios, P, Seitidis, G, Stewart, L, Clarke, M, Tudur-Smith, C, Mavridis, D, Hemmelgarn, B R, Holroyd-Leduc, J, Straus, S E & Tricco, A C 2022, ' Comparative safety and efficacy of cognitive enhancers for Alzheimer's dementia: a systematic review with individual patient data network meta-analysis ', BMJ Open, vol. 12, no. 4, e053012 . https://doi.org/10.1136/bmjopen-2021-053012
ObjectiveTo examine the comparative efficacy and safety of cognitive enhancers by patient characteristics for managing Alzheimer’s dementia (AD).DesignSystematic review and individual patient data (IPD) network meta-analysis (NMA) based on our prev